Philippine FDA Medical Device Registration

Medical devices and in vitro diagnostics in the Philippines are regulated by the Philippine Food and Drug Administration and its Center for Device Regulation, Radiation Health, and Research. The product route and certificate type depend on the device, risk class, and current implementation rules. Manufacturers should use the official Philippine FDA website and current CDRRHR circulars when planning a filing.

Philippines medical device classification

The Philippines applies the ASEAN risk framework: Class A is the lowest risk and Class D the highest. Classification considers intended use, invasiveness, duration of contact, active functions, and the consequences of an incorrect result or device failure. IVDs are also regulated and may require product authorization; their applicable product route must be assessed.

Depending on the applicable route, a device may require a Certificate of Medical Device Notification (CMDN) or a Certificate of Medical Device Registration (CMDR). The FDA has been moving designated applications into its eServices portal, so teams should confirm the current certificate and submission channel for their product rather than relying on a historical class-only summary.

Local company and dossier

A foreign manufacturer generally needs a Philippine-based licensed establishment to act as importer, distributor, and product applicant as applicable. The local company needs the correct License to Operate and must be authorized by the manufacturer. The agreement should cover dossier access, certificate ownership, changes, renewals, complaints, adverse-event reporting, recalls, and transfer at termination.

Submission evidence commonly includes an ASEAN Common Submission Dossier Template package or route-specific equivalent, intended use, classification rationale, device description, labeling and instructions for use, manufacturer and site details, ISO 13485 evidence, authorization documents, reference approvals or free-sale evidence where applicable, and technical, clinical, or performance data proportionate to risk.

Certificate maintenance and post-market controls

Certificate validity should be read from the issued authorization and current FDA rules; it is not safe to assume one universal term for every device. Before importation, verify that the approved models, manufacturer, site, labels, and local license remain current. Changes may require notification or approval. The local holder also needs procedures for complaints, reportable events, field safety corrective actions, recalls, distribution records, and responses to FDA inspections or information requests.

Philippines pathway and evidence decisions

Class alone is not a substitute for checking current circulars and transition status. IVD and software requirements must be assessed for the product; a draft-for-comment software circular is not a final binding rule merely because it contains proposed procedures.

Use the official FDA / CDRRHR instructions and related official process guidance for the filing scope. Maintain a controlled record of the chosen route, current evidence, open gaps, responsible parties and authority responses. Separate fees, document preparation, review and applicant work when planning the launch.

For a multi-country program, use the market directory to coordinate evidence reuse while retaining the local applicant, language, registration and postmarket requirements for each destination.